# ASPIRIN AND DIPYRIDAMOLE
> **ANDA206392** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2016-03-08
## Drug
- **FDA Application Number:** ANDA206392
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ASPIRIN AND DIPYRIDAMOLE
- **Generic name:** ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
- **Active ingredients:** ASPIRIN; DIPYRIDAMOLE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL PHARMS
- **Manufacturer:** AvKARE
- **First approval:** 2016-03-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206392)
---
*MORVS · CC0 1.0*